Ekene Enemchukwu

1 week ago | urologytimes.com | Ekene Enemchukwu |Hannah Clarke

Vaginal estrogen may be underutilized among female Medicare beneficiaries with genitourinary syndrome of menopause (GSM)-related conditions, according to findings from a recent study.

2 weeks ago | urologytimes.com | Ekene Enemchukwu |Hannah Clarke

While vaginal estrogen is the preferred treatment for addressing the long-term symptoms of genitourinary syndrome of menopause (GSM), there are barriers and misconceptions that limit its use, according to Ekene Enemchukwu, MD, MPH, FACS, URPS.